The evolutionary repurposing of eukaryotic genes into bacterial effectors.
真核基因在进化上重新利用为细菌效应子。
基本信息
- 批准号:RGPIN-2014-03641
- 负责人:
- 金额:$ 2.99万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to survive inside host cells, intracellular pathogens have evolved arsenals of effector proteins that manipulate host processes to create a replicative niche. One of the most extensive arsenals is maintained by Legionella pneumophila, an intracellular bacterium that persists in nature by growing within a wide range of freshwater protozoa. The objective of my research program is to understand how L. pneumophila commandeers and repurposes eukaryotic genes into bacterial effectors. **With a remarkably large cohort of over 300 translocated effectors and several easily cultivatable hosts, Legionella represents an unparalleled experimental model system to probe fundamental mechanisms of effector evolution. Many Legionella effectors contain eukaryotic-like domains, suggesting they may be the product of interdomain horizontal gene transfer. Little is known about the evolutionary path that leads from protozoan gene to a bona fide Legionella effector targeting host processes. Building on my lab's demonstrated expertise in bacterial genomics and experimental evolution, we will map where Legionella's large arsenal of effectors came from, how new effectors can be acquired, and what evolutionary processes support the functional transition of horizontally acquired genes into bona fide translocated effectors.**While other studies have focused on the biochemical activity of isolated Legionella effectors, the confluence of several technologies has placed previously intractable but long outstanding questions about effector origin and evolution within our reach. Using comparative genomics, transcriptional profiling, and experimental evolution, we will uncover the fundamental processes that continue to shape the ecological niche and host range of these environmentally ubiquitous bacteria. We anticipate that these studies will provide broad foundational insight into the evolutionary repurposing of genes acquired through horizontal gene transfer, a critical contributor to bacterial evolution.
为了在宿主细胞内生存,细胞内病原体进化出了一系列的效应蛋白,这些效应蛋白可以操纵宿主的过程来创造一个复制的生态位。嗜肺军团菌(Legionella pneumophilila)是最广泛的菌库之一,它是一种细胞内细菌,通过在各种淡水原生动物中生长而在自然界中持续存在。我的研究项目的目的是了解嗜肺乳杆菌是如何将真核生物基因转化为细菌效应物的。**军团菌拥有300多个易位效应体和几个易于培养的宿主,是一个无与伦比的实验模型系统,可以探索效应体进化的基本机制。许多军团菌效应物含有真核样结构域,表明它们可能是结构域间水平基因转移的产物。关于从原生动物基因到真正的军团菌效应物靶向宿主过程的进化路径知之甚少。基于我的实验室在细菌基因组学和实验进化方面的专业知识,我们将绘制军团菌大量效应物的来源,如何获得新的效应物,以及哪些进化过程支持水平获得基因的功能转变为真正的易位效应物。**虽然其他研究集中在分离的军团菌效应物的生化活性上,但几项技术的融合已经将以前棘手但长期悬而未决的效应物起源和进化问题置于我们的范围内。利用比较基因组学、转录谱分析和实验进化,我们将揭示继续塑造这些环境中无处不在的细菌的生态位和宿主范围的基本过程。我们预计这些研究将为通过水平基因转移获得的基因的进化再利用提供广泛的基础见解,这是细菌进化的关键因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ensminger, Alexander其他文献
Ensminger, Alexander的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ensminger, Alexander', 18)}}的其他基金
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPIN-2020-06636 - 财政年份:2022
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPAS-2020-00014 - 财政年份:2022
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPAS-2020-00014 - 财政年份:2021
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPIN-2020-06636 - 财政年份:2021
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPAS-2020-00014 - 财政年份:2020
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
The molecular circuitry of toxin-antitoxin systems and their contribution to microbial dormancy.
毒素-抗毒素系统的分子回路及其对微生物休眠的贡献。
- 批准号:
RGPIN-2020-06636 - 财政年份:2020
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The evolutionary repurposing of eukaryotic genes into bacterial effectors.
真核基因在进化上重新利用为细菌效应子。
- 批准号:
RGPIN-2014-03641 - 财政年份:2017
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The evolutionary repurposing of eukaryotic genes into bacterial effectors.
真核基因在进化上重新利用为细菌效应子。
- 批准号:
RGPIN-2014-03641 - 财政年份:2016
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The evolutionary repurposing of eukaryotic genes into bacterial effectors.
真核基因在进化上重新利用为细菌效应子。
- 批准号:
RGPIN-2014-03641 - 财政年份:2015
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
The evolutionary repurposing of eukaryotic genes into bacterial effectors.
真核基因在进化上重新利用为细菌效应子。
- 批准号:
RGPIN-2014-03641 - 财政年份:2014
- 资助金额:
$ 2.99万 - 项目类别:
Discovery Grants Program - Individual
相似海外基金
Repurposing flumazenil for pre-hospital intramuscular treatment of coma due to recreational drug overdose
重新利用氟马西尼用于院前肌肉注射治疗因娱乐性药物过量而导致的昏迷
- 批准号:
MR/X030237/1 - 财政年份:2024
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant
Repurposing Alpha-1-antitrypsin as a treatment for post-traumatic osteoarthritis
重新利用 Alpha-1-抗胰蛋白酶治疗创伤后骨关节炎
- 批准号:
MR/Y013883/1 - 财政年份:2024
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant
Repurposing Sodium Cromoglycate For Lymphangioleiomyomatosis (LAM): An Open Label, Proof Of Concept And Feasibility Study
重新利用色甘酸钠治疗淋巴管平滑肌瘤病 (LAM):开放标签、概念验证和可行性研究
- 批准号:
MR/Y008618/1 - 财政年份:2024
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant
SBIR Phase II: Repurposing RNA processing factors to edit RNA for the treatment of Dravet syndrome
SBIR II 期:重新利用 RNA 加工因子编辑 RNA 以治疗 Dravet 综合征
- 批准号:
2334756 - 财政年份:2024
- 资助金额:
$ 2.99万 - 项目类别:
Cooperative Agreement
Identifying novel & repurposing drug targets for Atrial Fibrillation MEDicines
识别小说
- 批准号:
EP/Z000211/1 - 财政年份:2024
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant
CNS Core: Small: Repurposing Smartphones to Minimize Carbon
CNS 核心:小型:重新利用智能手机以最大限度地减少碳排放
- 批准号:
2233894 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Standard Grant
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
虚拟药物筛选揭示了心肌细胞肥大的情境依赖性抑制
- 批准号:
10678351 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
ClinEX - 临床证据提取、表示和评估
- 批准号:
10754029 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别: